Arrowhead Pharmaceuticals has terminated the employment of chief scientific officer David Lewis, effective later this month, the company said in a regulatory filing that was made public on Thursday.
Vincent Anzalone, a vice president at Arrowhead (NASDAQ: ARWR), confirmed Lewis’... Read more »
San Antonio—A cybersecurity firm in San Antonio called Delta Risk, which has owners and board members who once held high-ranking federal government posts, has raised $3 million only a few months after acquiring a Philadelphia-based competitor, according to a regulatory... Read more »
The State of Cybersecurity, Xconomy’s first-ever dedicated conference on cybersecurity, is just one week away! It all takes place in WGBH’s auditorium in Boston at 1:30pm on Thursday, Dec. 8. Now’s your chance to save a little extra cash during... Read more »
The methods of honing the skills of sales people are getting more sophisticated, as companies turn to mobile technologies, data analytics, and even neuroscience to coax the best performance possible from their sales teams.
Investors see promise here: Qstream announced today... Read more »
San Diego-based AttackIQ, a cybersecurity startup providing a Web-based platform for assessing network defenses, has finally closed its Series A round of founding, after raising a total of $8.8 million over the past three years, according to co-founder and CEO Stephan... Read more »
After canceling three liver drug programs and slashing its staff, Arrowhead Pharmaceuticals has nothing left in clinical trials. But a separate partnership with another biotech company, Amgen, could signal where Arrowhead goes next.
The strategy shift became necessary after Arrowhead (NASDAQ:... Read more »
By a 392 to 26 vote, the U.S. House of Representatives has passed the omnibus healthcare legislation called the 21st Century Cures Act, bringing new funding for top Obama administration health priorities a big step closer to the outgoing president’s signature.... Read more »
Alexa, what’s the epicenter of innovation in speech as the new user interface?
A good case can be made for Seattle, following an announcement today from Techstars and Amazon (NASDAQ: AMZN).
Techstars, a top-tier startup accelerator with locations around... Read more »
Several drugs have been approved to treat multiple myeloma, a cancer of the bone marrow, in recent years. But it remains a nasty, persistent disease. Most everyone relapses.
Two rival groups, Bluebird Bio and researchers at the University of Pennsylvania, are... Read more »